Rheumatoid arthritis in the women's health initiative: Methods and baseline evaluation

American Journal of Epidemiology

Volumn 179, Issue 7, 2014, Pages 917-926

  Kuller, Lewis H ^a   Mackey, Rachel H ^a   Walitt, Brian T ^b   Deane, Kevin D ^c   Holers, V Michael ^c   Robinson, William H ^d   Sokolove, Jeremy ^d   Chang, Yuefang ^e   Moreland, Larry W ^e  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b WASHINGTON HOSPITAL CENTER   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

cytokines; epidemiologic methods; genetics; rheumatoid arthritis

Indexed keywords

ANTINUCLEAR ANTIBODY; ANTIRHEUMATIC AGENT; AZATHIOPRINE; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; GOLD; HLA DRB1 ANTIGEN; HYDROXYCHLOROQUINE; LEFLUNOMIDE; METHOTREXATE; MINOCYCLINE; PREDNISONE; RHEUMATOID FACTOR; SALAZOSULFAPYRIDINE; STEROID;

BIOASSAY; DISEASE PREVALENCE; DRUG; EPIDEMIOLOGY; GENETIC ANALYSIS; PEPTIDE; POLYMERASE CHAIN REACTION; SERUM; WOMENS HEALTH;

ADULT; ARTICLE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MIDDLE AGED; PREVALENCE; RHEUMATOID ARTHRITIS; SMOKING;

CYTOKINES; EPIDEMIOLOGIC METHODS; GENETICS; RHEUMATOID ARTHRITIS;

AGED; ANTIBODIES, ANTINUCLEAR; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; CYTOKINES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HLA-DRB1 CHAINS; HUMANS; IMMUNOLOGIC FACTORS; MIDDLE AGED; PEPTIDES, CYCLIC; POLYMERASE CHAIN REACTION; RHEUMATOID FACTOR; SEROEPIDEMIOLOGIC STUDIES; UNITED STATES; WOMEN'S HEALTH;

EID: 84896976590     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwu003     Document Type: Article

References (34)

1. McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011;365(23):2205-2219.
2. de Hair MJH, Lehmann KA, van de Sande MGH, et al. The clinical picture of rheumatoid arthritis according to the 2010 American College of Rheumatology/European League Against Rheumatism criteria: is this still the same disease? Arthritis Rheum. 2012;64(2):389-393.
3. Klareskog L, Catrina AI, Paget S. Rheumatoid arthritis. Lancet. 2009;373(9664):659-672.
4. Rantapää-Dahlqvist S, de Jong BAW, Berglin E, et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum. 2003;48(10):2741-2749.
5. van Venrooij WJ, Pruijn G.J.M. Citrullination: a small change for a protein with great consequences for rheumatoid arthritis. Arthritis Res. 2000;2(4):249-251.
6. van Venrooij WJ, Zendman AJW, Pruijn G.J.M. Autoantibodies to citrullinated antigens in (early) rheumatoid arthritis. Autoimmun Rev. 2006;6(1):37-41.
7. Kroot EJ, de Jong BA, van Leeuwen MA, et al. The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. Arthritis Rheum. 2000; 43(8):1831-1835.
8. Coenen D, Verschueren P, Westhovens R, et al. Technical and diagnostic performance of 6 assays for the measurement of citrullinated protein/peptide antibodies in the diagnosis of rheumatoid arthritis. Clin Chem. 2007;53(3): 498-504.
9. Aggarwal R, Liao K, Nair R, et al. Anti-citrullinated peptide antibody assays and their role in the diagnosis of rheumatoid arthritis. Arthritis Rheum. 2009;61(11):1472-1483.
10. Wiik AS, van Venrooij WJ, Pruijn G.J.M. All you wanted to know about anti-CCP but were afraid to ask. Autoimmun Rev. 2010;10(2):90-93.
11. Nepom GT, Byers P, Seyfried C, et al. HLA genes associated with rheumatoid arthritis. Identification of susceptibility alleles using specific oligonucleotide probes. Arthritis Rheum. 1989; 32(1):15-21.
12. Wordsworth BP, Lanchbury JS, Sakkas LI, et al. HLA-DR4 subtype frequencies in rheumatoid arthritis indicate that DRB1 is the major susceptibility locus within the HLA class II region. Proc Natl Acad Sci USA. 1989;86(24):10049-10053.
13. Rønningen KS, Spurkland A, Egeland T, et al. Rheumatoid arthritis may be primarily associated with HLA-DR4 molecules sharing a particular sequence at residues 67-74. Tissue Antigens. 1990;36(5):235-240.
14. Willemze A, van der Woude D, Ghidey W, et al. The interaction between HLA shared epitope alleles and smoking and its contribution to autoimmunity against several citrullinated antigens. Arthritis Rheum. 2011;63(7):1823-1832.
15. Meyer PW, Hodkinson B, Ally M, et al. HLA-DRB1 shared epitope genotyping using the revised classification and its association with circulating autoantibodies, acute phase reactants, cytokines and clinical indices of disease activity in a cohort of South African rheumatoid arthritis patients. Arthritis Res Ther. 2011;13(5):R160.
16. Laki J, Lundstrom E, Snir O, et al. Very high levels of anti-citrullinated protein antibodies are associated with HLA-DRB1*15 non-shared epitope allele in patients with rheumatoid arthritis. Arthritis Rheum. 2012;64(7):2078-2084
17. The Women's Health Initiative Study Group. Design of the Women's Health Initiative clinical trial and observational study. Control Clin Trials. 1998;19(1):61-109.
18. Walitt B, Mackey R, Kuller L, et al. Predictive value of autoantibody testing for validating self-reported diagnoses of rheumatoid arthritis in the Women's Health Initiative. Am J Epidemiol. 2013;177(9):887-893.
19. Kuller LH, Mackey R, Walitt BT, et al. Determinants of mortality among postmenopausal women who report rheumatoid arthritis in the Women's Health Initiative [published online ahead of print December 23, 2013]. Arthritis Rheum. (doi:10.1002/art38286).
20. Ng J, Hurley CK, Baxter-Lowe LA, et al. Large-scale oligonucleotide typing for HLA-DRB1/3/4 and HLA-DQB1 is highly accurate, specific, and reliable. Tissue Antigens. 1993; 42(5):473-479.
21. Chandra PE, Sokolove J, Hipp BG, et al. Novel multiplex technology for diagnostic characterization of rheumatoid arthritis. Arthritis Res Ther. 2011;13(3):R102.
22. Talabi MB, Mackey R, Moreland LW, et al. The associations of HLA-DR shared epitope alleles and serum cytokines among postmenopausal women with rheumatoid factor and anti-citrullinated protein antibody-positive rheumatoid arthritis [abstract]. Arthritis Rheum. 2012;64(suppl):S895.
23. Sokolove J, Bromberg R, Deane KD, et al. Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis. PLoS One. 2012;7(5):e35296.
24. Zhernakova A, Stahl EA, Trynka G, et al. Meta-analysis of genome-wide association studies in celiac disease and rheumatoid arthritis identifies fourteen non-HLA shared loci. PLoS Genet. 2011;7(2):e1002004.
25. Giles JT, Danoff SK, Sokolove J, et al. Association of fine specificity and repertoire expansion of anticitrullinated peptide antibodies with rheumatoid arthritis associated interstitial lung disease [published online ahead of print May 28, 2013]. Ann Rheum Dis. (doi:10.1136/annrheumdis-2012-203160).
26. Olson AL, Swigris JJ, Sprunger DB, et al. Rheumatoid arthritis- interstitial lung disease-associated mortality. Am J Respir Crit Care Med. 2011;183(3):372-378.
27. Lee H-S, Irigoyen P, Kern M, et al. Interaction between smoking, the shared epitope, and anti-cyclic citrullinated peptide: a mixed picture in three large North American rheumatoid arthritis cohorts. Arthritis Rheum. 2007;56(6): 1745-1753.
28. Källberg H, Ding B, Padyukov L, et al. Smoking is a major preventable risk factor for rheumatoid arthritis: estimations of risks after various exposures to cigarette smoke. Ann Rheum Dis. 2011;70(3):508-511.
29. Suzuki A, Yamada R, Yamamoto K. Citrullination by peptidylarginine deiminase in rheumatoid arthritis. Ann N Y Acad Sci. 2007;1108(1):323-339.
30. Thewissen M, Somers V, Venken K, et al. Analyses of immunosenescent markers in patients with autoimmune disease. Clin Immunol. 2007;123(2):209-218.
31. Scher JU, Ubeda C, Equinda M, et al. Periodontal disease and the oral microbiota in new-onset rheumatoid arthritis. Arthritis Rheum. 2012;64(10):3083-3094.
32. Deane KD, O'Donnell CI, Hueber W, et al. The number of elevated cytokines and chemokines in preclinical seropositive rheumatoid arthritis predicts time to diagnosis in an age-dependent manner. Arthritis Rheum. 2010;62(11):3161-3172.
33. Hughes-Austin JM, Deane KD, Derber LA, et al. Multiple cytokines and chemokines are associated with rheumatoid arthritis-related autoimmunity in first-degree relatives without rheumatoid arthritis: Studies of the Aetiology of Rheumatoid Arthritis (SERA). Ann Rheum Dis. 2013;72(6):901-907.
34. Kolfenbach JR, Deane KD, Derber LA, et al. A prospective approach to investigating the natural history of preclinical rheumatoid arthritis (RA) using first-degree relatives of probands with RA. Arthritis Rheum. 2009;61(12):1735-1742.